Abiopharma

🔍 BATE KENNETH (Director)

Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Reported stock transactions:

• Acquired 10,000 shares of Common Stock at $16.46 per share (directly)
  Date: 2025-08-15 | Code: M
• Sold 2,317 shares of Common Stock at $363.41 per share (directly)
  Date: 2025-08-15 | Code: S
• Sold 2,516 shares of Common Stock at $364.24 per share (directly)
  Date: 2025-08-15 | Code: S
• Sold 2,567 shares of Common Stock at $365.33 per share (directly)
  Date: 2025-08-15 | Code: S
• Sold 600 shares of Common Stock at $366.14 per share (directly)
  Date: 2025-08-15 | Code: S
• Sold 1,104 shares of Common Stock at $367.63 per share (directly)
  Date: 2025-08-15 | Code: S
• Sold 896 shares of Common Stock at $368.56 per share (directly)
  Date: 2025-08-15 | Code: S